Skip to main content
SpringerLink
Log in

The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

We evaluated the possible effects of a calcium entry blocking agent “verapamil” on new stone formation and/or regrowth of residual fragments after shock wave lithotripsy (SWL) during long-term follow-up (>30 months) and compared the results with the success rates of adequate fluid intake. A total of 70 patients treated with SWL were randomly divided into three different groups, in the first two of which the patients received different preventive measures with respect to stone recurrence and/or regrowth. While 25 patients received a calcium channel blocking agent, verapamil hydrochloride, beginning 3 days before SWL and continued 4 weeks after the procedure, an additional 25 patients were put in an enforced fluid intake program and the remaining 20 patients received no specific medication and/or measure apart from close follow-up. Patients were followed regularly with respect to the clearance/regrowth of the residual fragments and that of new stone formation during long-term follow-up (within a mean follow-up of 30.4 months). The overall stone recurrence rate was 14% (10/70). Of the patients who became stone free (12/25, 48%) in group I, only one patient (1/12, 8.3%) showed a new stone formation during long-term follow-up. The figure was 40% (4/10) in group II patients and 55% (5/9) in group III patients receiving no specific medication. Regarding the residual stone fragments (<5 mm) after SWL, again high fluid intake was found to be the most effective on stone regrowth rates (2/13, 15.3%). Patients treated with verapamil also had acceptable regrowth rates (3/15, 20%). Finally, verapamil treatment significantly improved the clearance of residual fragments; while 7 out of 15 patients with residual fragments passed these particles successfully, (46.5%) in this group; these figures were 46% (6/13) and 18% (2/13) in the remaining groups. Residual fragments located in lower calyces demonstrated a poor clearance rate with higher regrowth rates. Verapamil administration was found to be effective enough to limit the regrowth of residual fragments and also to facilitate residual fragment clearance after SWL. Patients receiving this medication seemed to pass the retained fragments easily in a shorter time than the others.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yu CC, Lee YH, Huang JK, Chen MT, Chen KK, Lin AT, Chang LS (1993) Long-term stone regrowth and recurrence rates after extracorporeal shock wave lithotripsy. Br J Urol 72(5 Pt 2):688–691

    PubMed  CAS  Google Scholar 

  2. Candau C, Saussine C, Lang H, Roy C, Faure F, Jacqmin D (2000) Natural history of residual renal stone fragments after ESWL. Eur Urol 37(1):18–22

    Article  PubMed  CAS  Google Scholar 

  3. Streem SB, Yost A, Mascha E (1996) Clinical implications of clinically insignificant store fragments after extracorporeal shock wave lithotripsy. J Urol 155(4):1186–1190

    Article  PubMed  CAS  Google Scholar 

  4. Beck EM, Riehle RA Jr (1991) The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones. J Urol 145(1):6–9; discussion 9–10

    Google Scholar 

  5. Newman DM, Lingeman JE (1989) Management of upper urinary tract calculi with extracorporeal shock-wave lithotripsy. Compr Ther 15(8):35–40

    PubMed  CAS  Google Scholar 

  6. Pak CY (2004) Medical management of urinary stone disease. Nephron Clin Pract 98(2):c49–c53

    Article  PubMed  Google Scholar 

  7. Preminger GM, Sakhaee K, Skurla C, Pak CYC (1985) Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 134:20–23

    PubMed  CAS  Google Scholar 

  8. Tapaneya-Olarn W (2002) The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis. J Med Assoc Thai 85(Suppl 4):S1143–S1149

    PubMed  Google Scholar 

  9. Tekin A (2002) Oral potassium citrate treatment for idiopathic hypocitraturia in children with calcium urolithiasis. J Urol 168(6):2572–2574

    Article  PubMed  CAS  Google Scholar 

  10. Soygür T (2002) Effect of potassium citrate therapy on stone recurrence and residual fragments after shock wave lithotripsy in şower caliceal urolithiasis: a randomized controlled trial. J Endourol 16(3):149–152

    Article  PubMed  Google Scholar 

  11. Cicerello E, Merlo F, Gambaro G, Maccatrozzo L, Fandella A, Baggio B, Anselmo G (1994) Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol 151(1):5–9

    PubMed  CAS  Google Scholar 

  12. Grossman E, Messerli FH (2002) Cardiac effects of calcium antagonists in hypertension. In: Epstein M (ed) Calcium antagonists in clinical medicine. Hanley and Belfus, Philadelphia, pp 207–228

    Google Scholar 

  13. Frishman WH (1994) Current status of calcium channel blockers. Curr Probl Cardiol 19:637–688

    Article  PubMed  CAS  Google Scholar 

  14. Mason RP, Marche P, Hintze TH (2003) Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine. Arterioscler Thromb Vasc Biol 23(12):2155–2163

    Article  PubMed  CAS  Google Scholar 

  15. Hoskin DH, Erickson SD, van der Berg CJ, Wilson DM, Smith LH (1983) The stone clinic effect in patients with idiopathic calcium nephrolithiasis. J Urol 13:1115–1118

    Google Scholar 

  16. Borghi L, Meschi T, Amato F, Briganti A, Navarini A, Giannini A (1996) Urine volume, water and recurrences in idiopathic calcium nephrolithiasis. A 5-year randomized prospective study. J Urol 155:839–843

    Article  PubMed  CAS  Google Scholar 

  17. Epstein M (1992) Calcium antagonists and renal protection: current status and future perspectives. Arch Intern Med 152:1573–1584

    Article  PubMed  CAS  Google Scholar 

  18. Epstein M (2002) Calcium antagonists and the kidney: implications for renal protection. In: Epstein M (ed) Calcium antagonists in clinical medicine. Hanley and Belfus, Philadelphia, pp 629–664

    Google Scholar 

  19. Epstein M, Loutzenhiser R (1990) Potential applicability of calcium antagonists as renal protective agents. In: Epstein M, Loutzenhiser R (eds) Calcium antagonists and the kidney. Hanley and Belfus, Philadelphia, pp 275–298

    Google Scholar 

  20. Hayashi K, Ozawa Y, Saruta T, Epstein M (2002) Renal hemodynamic effects of calcium antagonists. In: Epstein M (ed) Calcium antagonists in clinical medicine. Hanley and Belfus, Philadelphia, pp 559–578

    Google Scholar 

  21. Strohmaier WL, Koch J, Balk N, Wilbert DM, Bichler KH (1994) Limitation of shock-wave-induced renal tubular dysfunction by nifedipine. Eur Urol 25(2):99–104

    PubMed  CAS  Google Scholar 

  22. Strohmaier WL, Bichler KH, Koch J, Balk N, Wilbert DM (1993) Protective effect of verapamil on shock wave induced renal tubular dysfunction. J Urol 150(1):27–29

    PubMed  CAS  Google Scholar 

  23. Strohmaier WL, Abelius A, Billes I, Grossmann T, Wilbert DM, Bichler KH (1994) Verapamil limits shockwave induced renal tubular damage in vivo. J Endourol 8(4):269–273

    PubMed  CAS  Google Scholar 

  24. Strohmaier WL, Witte B, Nelde HJ (1994) Influence of nifedipine on stone formation and renal function in cholesterol-induced nephrolithiasis in rats. Urol Int 52(2):87–92

    PubMed  CAS  Google Scholar 

  25. Sarica K, Bakir K, Yağci F, Topçu O, Akbay C, Sayin N, Korkmaz C (1999) Limitation of possible enhanced crystal deposition by verapamil in renal parenchyma after shock wave application in rabbit model. J Endourol 13(5):343–347

    Article  PubMed  CAS  Google Scholar 

  26. Jan CR, Chen WC, Wu SN, Tseng CJ (1998) Nifedipine, verapamil and diltiazem block shock-wave-induced rises in cytosolic calcium in MDCK cells. Chin J Physiol 41(4):181–188

    PubMed  CAS  Google Scholar 

  27. Iguchi M, Ikegami M, Kiwamoto H, Umekawa T, Ishikawa Y, Kohri K, Kurita T (1993) Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers. Hinyokika Kiyo 39(5):425–431

    PubMed  CAS  Google Scholar 

  28. Baggio B, Gambaro G, Marchini F, Cicerello E, Borsatti A (1986) Effect of nifedipine on urinary calcium and oxalate excretion in renal stone formers. Nephron 43(3):234–235

    PubMed  CAS  Google Scholar 

  29. Bichler KH, Strohmaier WL, Schanz F, Nelde HJ, Gaiser I, Schulze E, Schreiber M (1985) Effect of calcium antagonists (nifedipine) on nephrocalcinosis and calcium excretion in the rat. Urol Int 40(1):13–21

    Article  PubMed  CAS  Google Scholar 

  30. Yaman Ö, Sarica K, Özer G, Soygür T, Kutsal O, Yaman LS, Göğüş O (1996) Protective effect of verapamil on renal histology following shock wave application in rabbit model. J Endourol 10(4):329–333

    PubMed  CAS  Google Scholar 

  31. Sarica K, Özer G, Soygür T, Yaman Ö, Özer E, Üstün H, Yaman LS, Göğüş O (1997) Preservation of shock-wave-induced renal histologic changes by dermatan sulphate. Urology 49(1):145–150

    Article  PubMed  CAS  Google Scholar 

  32. Akbay C, Sayin C, Sarica K, Soygür T, Sabuncuoğlu B (1998) Effect of verapamil on rabbit renal tissue after shock wave lithotripsy: an ultrastructural approach. Electron Microsc IV:493–494

    Google Scholar 

  33. Sarica K, Bakir K, Yağci F, Erbağci A, Topçu O, Uysal O (1999) Unilateral testicular torsion: protective effect of Verapamil on contralateral testicular histology. Urol Int 62(3):159–163

    Article  PubMed  CAS  Google Scholar 

  34. Sarica K, Erbağci A, Yağci F, Bakir K, Erturhan S, Uçak R (2004) Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria. Urol Res 32:271–277

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Memorial Hospital, Istanbul, Turkey

    Kemal Sarica

  2. Department of Urology, University of Gaziantep, Medical School, Gaziantep, Turkey

    Yener İnal, Sakip Erturhan & Faruk Yağci

Authors
  1. Kemal Sarica
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yener İnal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sakip Erturhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Faruk Yağci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kemal Sarica.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarica, K., İnal, Y., Erturhan, S. et al. The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urol Res 34, 184–189 (2006). https://doi.org/10.1007/s00240-006-0040-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-006-0040-x

Keywords

Search

Navigation